Profile
| Metric | Value |
|---|---|
| Full Name | Waters Corporation |
| Ticker | NYSE: WAT |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | waters.com |
| Employees | 7,600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $396.75 | |
| Price, 1D Change | +0.03% | |
| Market Cap | $24B | |
| - | ||
| PE Ratio | 36.48 | |
| Beta | 0.96 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +0.07% | |
| EPS | $10.71 | |
| EPS, 1Y Change | -1.16% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $10.71 | |
| EPS Estimate | $13.11 | |
| EPS Est. Change | +22.41% | |
| Revenue | $2.96B | |
| Revenue Estimate | $3.16B | |
| Revenue Est. Change | +6.87% | |
| Current Price | $396.75 | |
| Price Target | - | $405.00 |
| Price Tgt. Change | - | +2.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.69 | $10.84 | -7.31% | |
| $11.80 | $10.71 | -9.25% | |
| $13.11 | N/A | +22.41% | |
| $14.29 | N/A | +33.43% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.95B | $2.96B | +0.11% | |
| $2.94B | $2.96B | +0.61% | |
| $3.16B | N/A | +6.87% | |
| $3.36B | N/A | +13.55% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +6.03% | |
| Price, 3Y | +23.83% | |
| Market Cap, 1Y | +6.29% | |
| Market Cap, 3Y | +24.73% | |
| Revenue, 1Y | +0.07% | |
| Revenue, 3Y | +6.19% | |
| EPS, 1Y | -1.16% | |
| EPS, 3Y | -4.11% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $396.75 | |
| SMA 200 | $340.08 | |
| SMA 200 vs Price | -14.28% | |
| SMA 50 | $383.78 | |
| SMA 50 vs Price | -3.27% | |
| Beta | 0.96 | |
| ATR | $8.63 | |
| 14-Day RSI | 60.28 | |
| 10-Day Volatility | 20.44% | |
| 1-Year Volatility | 36.37% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.96B | |
| EPS | $10.71 | |
| Gross Profit | $1.76B | |
| Gross Margin | 59.43% | |
| Operating Profit | $837.92M | |
| Operating Margin | 28.32% | |
| Net Income | $637.83M | |
| Net Margin | 21.56% | |
| EBITDA | $1.02B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.89 | |
| Current Ratio | 2.11 | |
| Quick Ratio | 1.34 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 9.69 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 36.48 | |
| PS Ratio | 7.61 | |
| PB Ratio | 10.13 | |
| EV/EBITDA | 23.92 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.83B | |
| Cash & Equivalents | $324.42M | |
| Total Assets | $4.55B | |
| Current Assets | $1.54B | |
| Total Liabilities | $2.73B | |
| Current Liabilities | $789.76M | |
| Total Debt | $1.70B | |
| Short Term Debt | $25.54M | |
| Accounts Payable | $99.93M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.12B | |
| Operating Expenses | $920.27M | |
| Cost Of Goods Sold | $1.20B | |
| SG&A | $690.15M | |
| D&A | $191.83M | |
| Interest Expense | $0.00 | |
| Income Tax | $117.03M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $762.12M | |
| CFI | -$144.02M | |
| CFF | -$696.68M | |
| Capex | $142.48M | |
| Free Cash Flow | $619.64M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| William Blair | ||
| Wells Fargo | → | |
| Wolfe Research | → | |
| Morgan Stanley | ||
| Wells Fargo | → | |
| TD Cowen | → | |
| JP Morgan | → | |
| Rothschild & Co | ||
| Wells Fargo | → | |
| Deutsche Bank | → |
Analyst sentiment
Institutional ownership
Screeners with WAT
Data Sources & References
- WAT Official Website www.waters.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000697/000119312525263533/0001193125-25-263533-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000697/000119312525034579/0001193125-25-034579-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- WAT Profile on Yahoo Finance finance.yahoo.com/quote/WAT
- WAT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wat
FAQ
What is the ticker symbol for Waters Corporation?
The ticker symbol for Waters Corporation is NYSE:WAT
Does Waters Corporation pay dividends?
No, Waters Corporation does not pay dividends
What sector is Waters Corporation in?
Waters Corporation is in the Healthcare sector
What industry is Waters Corporation in?
Waters Corporation is in the Diagnostics & Research industry
What country is Waters Corporation based in?
Waters Corporation is headquartered in United States
When did Waters Corporation go public?
Waters Corporation initial public offering (IPO) was on November 17, 1995
Is Waters Corporation in the S&P 500?
Yes, Waters Corporation is included in the S&P 500 index
Is Waters Corporation in the NASDAQ 100?
No, Waters Corporation is not included in the NASDAQ 100 index
Is Waters Corporation in the Dow Jones?
No, Waters Corporation is not included in the Dow Jones index
When was Waters Corporation last earnings report?
Waters Corporation's most recent earnings report was on November 4, 2025
When does Waters Corporation report earnings?
The next expected earnings date for Waters Corporation is February 11, 2026